|
|
|
|
||
Re: Don't sell your shares. CX-2009 expandedMy major concerns were Probady safety issues, and CX-2009 in particular. Now CX-2009 trial has been up recruiting for more than a year since Jun 1, 2017, its recruiting site are increased from 3 to 8, 8 to 17, 17 to 26 now in 12 months which certainly indicates dose escalation part is moving forward well. After CX-2009 added additional 9 new active trial sites to speed up its enrollment, I decided it is time to add shares(bought 10K shares today @23.95) |
return to message board, top of board |